| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.07 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.07 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.087 | 0.07 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.095 | 0.07 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.07 | 0.07 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.07 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.07 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.1 | 0.07 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |